Meningococcal Vaccines: Challenges and Prospects

Vaccines (Basel). 2020 Dec 4;8(4):738. doi: 10.3390/vaccines8040738.

Authors

Priyal Bagwe¹, Lotika Bajaj¹, Rikhav Gala², Susu M Zughaier³, Mohammad N Uddin¹, Martin J D'Souza¹

Affiliations

¹ Center for Drug Delivery Research, Vaccine Nanotechnology Laboratory, College of Pharmacy, Mercer University, Atlanta, GA 30341, USA.
² Fraunhofer USA Center for Molecular Biotechnology, Newark, DE 19711, USA.
³ College of Medicine, QU Health, Qatar University, Doha P.O. Box 2713, Qatar.

Abstract

Neisseria meningitidis is a gram-negative bacterium that causes a severe acute infection, called the meningococcal disease [...].

Publication types

Editorial